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Glomerular sieving of high molecular weight proteins in proteinuric
rats. To characterize the permeability of the glomerular capillary wall to
high molecular weight proteins in normal and proteinuric rats, we
determined the glomerular sieving coefficients (GSC) of radioiodinated
marker proteins of known size and charge by means of a paired label,
tissue accumulation method previously validated in this laboratory. In
one group of rats (Series A) the GSCs of '251-anionic IgO (algO—
molecular weight [mol wt] 150,000, p1 4.9) and '311-neutral IgG (nIgG—
p1 7.4 to 7.6) were measured simultaneously. In Series B, the GSC of a
second anionic marker, '311-human ceruloplasmin (Crp—mol wt
137,000, p1 4.9) was compared to that of '251-nIgG. As in the previous
report, the labeled proteins were not degraded or deiodinated during the
20 minute clearance period for GSC determination. Within Series A and
B, three subgroups of rats were studied: control saline—infused rats, rats
made acutely proteinuric by infusion of the polycation hexadimethrine
(HDM), and rats with chronic doxorubicin (Adriamycin®—Adria)
nephrosis. In the control rats, GSCs for the anionic markers aIgG
(Series A) or Crp (Series B) were significantly greater than that of nIgG
(both series). These large proteins crossed the filtration bamer by a
different pathway from that available to smaller neutral molecules the
size of albumin, which in our previous study had a much higher GSC
than a native, anionic albumin marker. In a third group of control rats
only (Series C), the GSCs of native anionic bovine albumin (BSA) and
nIgG were compared directly. The GSC of BSA (0.0029) was only
slightly larger than the GSC of nIgG (0.0025), indicating that most of the
native albumin crosses the glomerular capillary wall via a nonselective
pathway similar to that available to nIgG. The results in the control
groups are compatible with recently—described heteroporous models of
glomerular size selectivity. In the HDM proteinuric rats of both series,
the filtration of all three markers was significantly increased, although
the GSCs of the anionic markers continued to exceed that of nlgG. The
finding of increased nIgG filtration in HDM rats confirms our previous
observation that HDM, although it binds to and neutralizes anionic sites
in glomerular basement membrane, induces a structural change which
leads to altered pore size distribution. Adria rats also had increased
GSCs of all markers, although the increase was not as great as in HDM
rats, and the GSCs of the anionic and neutral markers became equal.
The finding of increased nIgG filtration in the Adria rats demonstrates
that altered size dependence of permselectivity, shown by others using
polysaccharide probes, can be detected with protein markers as well, if
they are of large enough size.
The glomerular capillary wall is a charge— and size—selective
barrier to the filtration of macromolecules [1—4]. In the molec-
ular size range from approximately 20 to 45 A, anionic proteins
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or polysaccharides are filtered less readily than neutral mole-
cules of equivalent size, a phenomenon attributed to the pres-
ence within the capillary wall of anionic components which
create electrostatic repulsion for negatively charged molecules
[5]. Although in theory urinary losses of an anionic protein such
as albumin in proteinuric disease states could be explained
entirely by a loss of anionic sites within the capillary wall [6, 7],
it is now apparent that in most animal [8—10] and human [10—13]
nephropathies, there is a change in size—dependent permselec-
tivity for large molecules. In some disorders, it has been
proposed that the appearance of large nonselective pores ac-
counts for the entire increment in filtration of anionic as well as
neutral proteins [8].
The polycation hexadimethrine (HDM) binds to anionic sites
in the glomerular basement membrane (GBM) in vivo and
causes severe, acute reversible proteinuna [14, 15]. Using
radiolabeled bovine albumins of anionic or neutral isoelectric
point (p1), we have previously reported that HDM induces a
significant increase in the filtration of the neutral albumin
marker [161. Because the increments in neutral and anionic
marker filtration were similar, the increased filtration of rat
albumin induced by HDM could be entirely attributed to an
increase in pore size, despite the evidence that this polycation
initially acts by binding to GBM anions. These results, along
with those of others [17, 18], indicate that the negative charges
on at least some population of GBM anionic components are
important in maintaining normal GBM structure, in addition to
charge density. Because the original evidence for altered size
dependence of glomerular permeability in the HDM model was
the demonstration by qualitative techniques of increased excre-
tion of the large, relatively—neutral molecule IgG in the urine of
HDM infused rats [14], we have now extended our earlier
observations in this model by performing sieving studies using
anionic and neutral IgG markers. To confirm results obtained
using the IgGs, we also compared the filtration of neutral IgG to
that of a second anionic protein of similar size, ceruloplasmin.
In our previous report on albumin marker filtration [16], we
demonstrated that in a second model of proteinuria induced by
doxorubicin, the increased filtration of albumin was almost
entirely due to a loss of the charge barrier, with no significant
increase in filtration of a neutral marker the size of albumin. An
earlier study by others had shown evidence for altered perme-
ability to large neutral dextrans in this model [8]. Since larger
markers would be predicted to be more sensitive probes for
detection of the appearance of a population of a few large
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"pores" in the glomerular capillary wall, we also performed




Purified human IgG, bovine serum albumin (BSA), succinic
anhydride, 6-aminohexanoic acid, inulin and hexadimethrine
were obtained from Sigma Chemical, St. Louis, Missouri,
USA. Doxorubicin (Adriamycin®—Adria) was purchased from
Adria Labs, Columbus, Ohio, USA. QAE-Sephadex® A50,
Sephadex® types G75 and G100, Sephacryl® S-300 and
chromatofocusing reagents (Polybuffer® and Polybuffer® ex-
changer) were obtained from Pharmacia, Piscataway, New
Jersey, USA. Diethylaminoethyl (DEAE)-cellulose (DE-52®)
was obtained from Whatman, Maidstone, Kent, UK.
Preparation of radiolabeled protein markers
For use as an in vivo marker, BSA was purified by gel
filtration chromatography on Sephacryl S-300, with 0.15 M
sodium phosphate buffer as the eluent. Fractions containing the
main protein peak were pooled, dialyzed against distilled water,
using cellulose acetate tubing with a 50,000 dalton molecu-
lar—weight cutoff, and lyophilized.
Neutral and anionic markers were prepared from purified
human IgG. A neutral marker (nIgG) of narrow p1 range was
obtained by chromatofocusing. Two hundred mg of IgG were
applied to a 1.6 x 50 cm column of Polybuffer exchanger 94
which had been equilibrated with 0.025 M ethanolamine—acetic
acid, pH 9.4. The column was eluted with Polybuffer 96, pH
6.0. Fractions with pH 7.3 to 7.6 in the pH gradient were
pooled, dialyzed against distilled water to remove Polybuffer,
and lyophilized.
An anionic IgG marker (aIgG) was prepared by succinylation
of native human IgG [19]. One hundred mg of lgG were
dissolved in 50 ml distilled water. The pH was adjusted to 8.5
with I M NaOH. Solid succinic anhydride (33 mg) was added to
the reaction mixture over 30 minutes. The pH was held at 8.0 to
8.5 by titration with 1 si NaOH. The reaction was allowed to
proceed overnight at 4°C. The mixture was dialyzed against
water to remove succinic acid, and lyophilized.
Human ceruloplasmin (Crp) was employed as a second
anionic marker with molecular weight similar to IgG. Because
commercial ceruloplasmin preparations contained significant
amounts of other plasma proteins, we prepared ceruloplasmin
from outdated human plasma [20, 21]. Plasma (2 liters) was
mixed with 2 liters of 40 mt 6-amino—hexanoic acid. The pH
was adjusted to 6.8 with I M H3PO4. The mixture was applied to
a 2.6 x 100 cm column of QAE-Sephadex which had been
equilibrated with 50 m potassium phosphate buffer, pH 6.8.
An intense blue—green band formed at the top of the column.
The column was washed extensively with potassium phosphate
buffer, pH 6.8, at 50 m and 200 m. Buffer molarity was then
increased to 250 m. When the blue band began to move down
the column, buffer molarity was increased to 300 m, and
fractions of column effluent were collected. All fractions which
appeared blue by visual examination were pooled and precip-
itated by 33% saturated ammonium sulfate. The precipitate was
collected by centrifugation and discarded. The supernatant was
precipitated a second time with 45% saturated ammonium
sulfate. This second precipitate was collected by centrifugation,
dissolved in 25 m potassium phosphate buffer, pH 6.8, and
dialyzed against this buffer. The material was next applied to a
2.6 x 100 cm column of DE-52 DEAE-cellulose which had been
equilibrated with 25 m potassium phosphate, pH 6.8. The
proteins were eluted with a buffer gradient from 50 to 200 mM
potassium phosphate at the same pH. The absorbance(A) of
each fraction at 610 nm and 280 nm was measured
spectrophotometrically (Bausch and Lomb model 710, Roches-
ter, New York, USA). Fractions with A610/A280 of 0.04 or
greater were pooled and concentrated in an ultrafiltration cell
(Amicon 8050, Danvers, Massachusetts, USA) using an XM 100
membrane. For the final step, the concentrated preparation was
applied to a 2.6 x 100 cm column packed with Sephadex G100
and eluted with 50 m potassium phosphate buffer. Fractions
with A/A280 of 0.04 or greater were again pooled, concen-
trated to approximately 5 mg/mI, and stored frozen at —70°C
until radiolabeling. The Crp preparation was analyzed by im-
munoelectrophoresis in a 1% agarose gel. After electrophoresis
and reaction with anti-whole human serum, a single precipitin
arc was present. This arc had a mobility typical of Crp.
Albumin, run on the same gel as a standard, was not detected in
the Crp preparation.
For use as filtration markers, the modified or purified proteins
were labeled with 125J or ''i nIgG, Crp and BSA were labeled
by a lactoperoxidase—glucose oxidase method (Enzymobeads,
Bio-Rad, Richmond, California, USA). Because this method
occasionally reversed the succinylation of aIgG, this protein
was labeled using '251-labeled Bolton—Hunter reagent (Amer-
sham, Arlington Heights, Illinois, USA). Specific activities of
labeled nIgG, aIgG, Crp, and BSA preparations ranged from 2.0
to 6.5 Ci/g protein. The percentage of total radioactivity
precipitable by 12% trichloroacetic acid (TCA) was 75 to 88%
for '311-Crp, 88 to 98% for the IgG markers, and 97% for
'311-BSA.
Characterization of markers in vitro
The in vitro properties of '311-BSA were extensively evalu-
ated in a previous report [16].
The molecular weight (mol wt) of mammalian ceruloplasmins
has been reported to be in the range from 120,000 to 150,000
[20—22]. Because of this relatively broad range of reported
MWs, the MW and molecular radius (r) of the purified human
Crp prepared for this study were determined by gel permeation
chromatography [231. A sample containing unlabeled Crp and
1311-Crp was applied to a 1.6 x 50 cm column packed with
Sephacryl S-300 and equilibrated with 0.15 M NaCI, 0.05 M
sodium phosphate buffer, pH 7.4 (PBS). Proteins were eluted
from the column with PBS. Molecular weight standards were
chymotrypsinogen A (mol wt 25,000, r = 21 A), bovine serum
albumin (mol wt 69,000, r = 36 A), and human IgG (mol wt
150,000, r = 52 A). Total column volume (Vi) and void volume
(V0) were determined by the elution volumes (Ye)ofpotassium
and blue dextran, respectively. The fractional volume (Kay)
available to each standard or labeled marker was calculated as
(Ve-Vo)/(VrV0). For the three standards, log mol wt and log r
were plotted versus Kay and straight lines were fitted to the data
by linear regression analysis. The lines were used to determine
the mol wt and r of Crp and '311-Crp.
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To determine whether charge modification or radiolabeling
affected the mol wt of aIgG or nIgG, a sample containing
unlabeled human IgG, '251-aIgG, and '311-nIgG was analyzed on
a Sephacryl S300 column as described above. The VeS of the
protein and radioactivity peaks were compared.
The pls of the markers were determined by isoelectric
focusing (IEF) in polyacrylamide gel slabs (PAGplates, LKB,
Gaithersburg, Maryland, USA) or in agarose slabs [14, 16].
After focusing, lanes in which the labeled markers had been
applied were cut from the gels, sectioned at 0.5 cm intervals,
and counted in a gamma counter. The pH gradient in the gels
was determined by measuring pH of the ampholytes diffusing
out of the cut gel sections, as well as by location of Coomassie
Blue—stained standards in lanes adjacent to those which had
been sectioned for counting.
Characterization of markers in vivo
To determine the apparent mol wt of circulating and excreted
marker in vivo, a 5 pCi bolus of labeled marker was infused
intravenously into a 200 g rat. Each marker (nIgG, aIgG, or
Crp) was studied individually in a single rat. Beginning imme-
diately after the marker bolus, urine was collected for 20
minutes. At the end of the urine collection, a plasma sample
was taken. Plasma and urine samples were mixed with approx-
imately 1 mg of unlabeled human IgG and chromatographed on
Sephacryl S-300 columns as described above. The Vs of
radioactivity peaks in plasma and urine were compared to that
of the IgG protein peak.
Circulating marker might be degraded in vivo into fragments
small enough such that they would essentially elute at the total
column volume on a relatively high—porosity gel such as Seph-
acryl S300, and therefore not be distinguished from free
radioiodine, present in small amounts in the labeled prepara-
tions. To examine this possibility, plasma and urine samples
from the marker—infused rats were also chromatographed on a
1.6 x 50cm column packed with a more highly cross—linked gel,
Sephadex G75,
As an additional check on the molecular weight of circulating
radioactivity in animals given radiolabeled nIgG or aIgG,
plasma, urine and kidney samples obtained as described above
were analyzed by sodium dodecyl sulfate—polyacrylamide gel
electrophoresis (SDS-PAGE) followed by gel autoradiography,
performed as previously described [16]. Preliminary experi-
ments showed a marked discrepancy between estimates of the
mol wt of Crp obtained by SDS-PAGE and gel permeation
chromatography, so that this technique was not applied to
tissue samples from the '311-Crp infused rat.
Kidney tissue contains a deiodinase [24] which in theory
might release radioiodine from the labeled markers into the
TCA-soluble pool of radioactivity and therefore lead to under-
estimation of filtered marker. In a previous report, we showed
that no significant deiodination of labeled albumin occurred
during a 20 minute period [16]. To show that the high mol wt
markers used in the current study were also not deiodinated,
the effect of excess monoiodotyrosine (MIT), a competitive
inhibitor of deiodinases, on the proportion of radioactivity
precipitable by TCA was determined. Two—hundred g rats were
prepared as for clearance studies and allowed to equilibrate
after surgery on an infusion of saline, 0.25 mI/mm. Control rats
were continued on saline infusion at this rate for an additional
hour. A second group of rats was given a 1 ml intravenous bolus
of 50 m MIT in saline, followed by infusion of MIT, 10
pmoles/min in saline, 0.25 ml/min, for one hour. We showed
previously [16] that pretreatment with MIT in this fashion
inhibits deiodination of subsequently—administered radiola-
beled MIT, and would therefore be expected to cause a signif-
icant increase in the proportion of TCA-precipitable radioactiv-
ity if marker deiodination occurred to an important extent.
After preinfusion with saline (6 rats) or MIT (6 rats), rats
were given a 5 pCi bolus of either nIgG (3 controls, 3 MIT-
infused rats), aIgG (I control and I MIT-infused rat) or Crp (2
control and 2 MIT-infused rats). A 20 minute urine collection
was begun after marker bolus administration. A plasma sample
was obtained at 18 minutes. At completion of urine collection,
the abdomen was opened and the kidneys were flushed with
saline via an aortic cannula prior to removal. Plasma, urine, and
renal homogenate samples were precipitated with 12% TCA and
counted to determine the proportion of TCA-insoluble (intact)
marker to TCA-soluble free radioiodine.
Paired label marker, glomerular sieving experiments
The permeability of the glomerular capillary wall to the
radiolabeled marker proteins was determined in paired—label,
tissue accumulation experiments performed as previously de-
scribed and validated [16]. The method accounts for the reab-
sorbed fraction of filtered protein markers by measuring total
marker accumulation in a filtering kidney, and subtracting an
estimate of interstitial marker obtained from the animal's other
kidney, which was rendered nonfiltering by ureteral occlusion
after mannitol infusion [25]. Two hundred g, female Sprague—
Dawley rats were anesthetized with intraperitoneal pentobarbi-
tal, 50 mllkg, and maintained on a warm pad. A femoral artery
catheter (PE-50) was inserted to permit blood sampling and
infusion of saline at 0.20 ml/min. A 1.0 ml priming dose of
inulin, 15 mglml dissolved in 10% mannitol, was administered
through a jugular vein catheter and followed by a maintenance
infusion of the same solution at 0.05 mI/mm. The relatively high
total rate of volume infusion (0.25 mI/mm) was necessary
because hexadimethrine infusion is only tolerated by volume
expanded rats. During a typical three hour clearance study,
animals received a total volume expansion amounting to 10 to
15% of body weight. Through a midline abdominal incision, the
bladder was catheterized (PE-90) for urine collection. Animals
were then permitted to equilibrate on the infusions described
until sequential, five—minute urine volumes differed by less than
5% (approximately one hr).
Control rats continued to receive saline via the femoral artery
catheter throughout the study. HDM rats were rendered acutely
proteinuric by addition of HDM, 20 g/min, to the saline
infusion for 45 to 60 minutes. In a previous study [15], we have
shown that infusion of HDM at this dose and at this rate of
volume infusion does not produce more than transient alter-
ations in renal hemodynamic parameters. Adria rats were
studied two to six weeks after tail—vein infusion of Adria, 7.5
mg/kg [26]. After equilibration for all rats, and after induction of
proteinuria in HDM rats, the left kidney was rendered non-
filtering by ureteral ligation during the ongoing mannitol
diuresis [25]. Forty—five minutes after ureteral ligation, animals
were given an intravenous bolus of 2 to 4 pCi (approximately 1
to 3 p.g of each protein) of paired anionic and neutral markers.
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Three series of sieving experiments were carried out. In Series
A, simultaneous determinations of the filtration of differently
charged IgG markers ('311-nIgG and '251-aIgG) were performed.
Series B was undertaken to compare the filtration of neutral IgG
('251-nIgG) to that of a second unmodified anionic protein of
similar molecular weight, '311-Crp. Within Series A and B, three
groups of six to eight rats each (control, HDM, or Adria) were
studied. The third series, Series C, consisted of eight sa-
line—infused control rats given anionic 1311-native BSA and
'251-nIgG simultaneously. No proteinuric rats were studied in
Series C.
Plasma levels of the IgG markers remained essentially con-
stant without a maintenance infusion. For Crp and BSA, the
initial i.v. bolus was followed by addition to the ongoing inulin
infusion of sufficient labeled protein to maintain constant
plasma levels during the clearance period.
Mter marker administration, a 20 minute urine collection was
begun. Plasma samples were obtained at 3, 10 and 17 minutes
after the priming marker injection. After the final arteri-
al—plasma sample was taken, a left—renal—vein plasma sample
for determination of inulin extraction by the left kidney was
obtained with a 30 gauge needle.
At the end of the clearance period, the aorta was clamped
above the renal arteries with an aneurysm clamp. Using a
polyethylene catheter (PE-90) inserted into the abdominal
aorta, the kidneys were perfused with a minimum of 100 ml of
saline at 100 mm Hg. A small hole was made in the left renal
vein to facilitate perfusion of the kidneys. The flushed kidneys
were removed and weighed. Weighed segments of each kidney
were rapidly homogenized in 10% TCA in a glass tissue
homogenizer.
Determinations and calculations
Radioactivity in plasma, urine, kidney homogenate, column
fractions or gel sections was determined in a dual channel
gamma counter (Gamma 5500, Beckman Instruments, Irvine,
California, USA), with crossover correction. Inulin concentra-
tion was determined by the anthrone method. Urinary excretion
of rat albumin and IgG was quantitated by rocket im-
munoelectrophoresis (IEP), using commercially obtained anti-
sera monospecific for the appropriate antigen (Cooper Biomed-
ical, West Chester, Pennsylvania, USA).
For sieving coefficient calculations, only TCA-insoluble ra-
dioactivity was used. The glomerular sieving coefficient (GSC-
filtrate—to—plasma concentration ratio of the marker) was cal-
culated as follows: reabsorbed marker in the right filtering
kidney was determined as (right kidney weight) x (right kidney
cpmlg — left kidney cpmlg). Total filtered marker (right kidney
reabsorbed marker plus urinary marker) was divided by average
plasma marker, and then by inulin clearance, to obtain the
GSC.
Statistics
Within each series of experiments, the means of data for the
three groups were tested for significant differences by analysis
of variance (ANOVA) performed using the SAS procedure
GLM (SAS, Cary, North Carolina, USA). Where an overall test
for significant differences by group was positive (P < 0.05), the
least—squares (corrected) means of individual groups were
compared (SAS procedure LSMEANS). In cases in which the
variances of groups differed markedly, logarithmic transforma-
tion of the data was performed. In some instances (noted in
text), group means were compared by t-tests.
Results
Characterization of markers in vitro and in vivo
The mol wt and r of Crp were determined by gel permeation
chromatography on Sephacryl S300. Regression lines fitted to
the data for Kay as a function of mol wt and r for the three
standard proteins had r2 values of 0.96 and 0.97, respectively.
Using these regression lines, values of 137,000 and 50 A were
obtained for the MW and r of unlabeled Crp. '31-Crp co-eluted
with unlabeled Crp, indicating no effect of radioiodination on
mol wt.
Since the size of human IgG is well established (mol wt
150,000, r = 52 A), the mol wt of IgG used in this study was not
determined on columns calibrated with standards. However,
the MWs of aIgG and nIgG were compared to that of unlabeled
IgG by Sephacryl S300 chromatography. The labeled IgGs
coeluted with the unlabeled protein, indicating no change in
apparent mol wt after charge modification or radioiodination.
To examine the possibility that in vivo degradation of the
markers to lower mol wt polypeptides had occurred, the elution
profiles of radioactivity in plasma and urine samples obtained
from marker infused rats were compared to that of unlabeled
IgG determined in the same chromatographic experiment. In
the animals given labeled aIgG or nIgG, the peak of radioactiv-
ity in plasma and urine co-eluted with the IgG standard. Plasma
and urine samples from the animal given Crp had a radioactivity
peak eluting consistently 1.5 ml after the IgG peak, in keeping
with its slightly smaller size. To look for smaller polypeptide
marker fragments that might elute at the total column volume
on a Sephacryl S300 column, plasma and urine samples from
marker infused rats were also chromatographed on Sephadex
0-75 columns. On columns of this more highly cross—linked gel,
all of the plasma and urine radioactivity in samples from the
marker infused rats eluted at the void volume, indicating that
the radioiodine was attached to a molecule of mol wt greater
than approximately 70,000. As an additional proof that the
labeled IgGs circulated in intact form, autoradiograms of SDS-
PAGE gels showed a single band of radioactivity in samples of
plasma, urine, and kidney from rats given aIgG or nIgG. All of
these bands comigrated with the unlabeled IgG standard.
Isoelectric focusing of the radiolabeled proteins followed by
counting of the gel sections gave p1 values of 4.9, 7.4 to 7.6, and
4.9 for aIgG, nIgG, and Crp, respectively. These p1 values were
not different from those obtained by isoelectric focusing of the
unlabeled proteins.
Table 1 summarizes the results of the in vivo experiments
performed to detect possible deiodination of the labeled mark-
ers. Rats given an intravenous bolus and infusion of MIT
previously shown to be sufficient to inhibit markedly the
deiodination of an appropriate delodinase substrate, 125I-MIT
[161, were compared to rats given saline alone. For all three
markers, the MIT-pretreated rats had no major increase in the
proportion of intact marker precipitable by TCA in plasma,
kidney, or urine. The higher TCA precipitability of labeled nIgG
in kidney and urine of the first rat in the saline and MIT groups
is most likely explained by the fact that these two rats were
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Table 1. Effect of MIT on TCA precipitability of radioactivity in
plasma, urine and kidney
Marker Infusion Plasma Kidney Urine
nlgGa saline 97 78 36
nIgG saline 94 70 6
nIgG saline 95 67 6
nlgGb MIT 96 88 23
nIgG MIT 95 76 8
nIgG MIT 95 75 9
aIgG saline 94 62 20
aIgG MIT 95 88 II
CRP saline 74 55 5
CRP saline 78 48 5
CRP MIT 72 57 5
CRP MIT 68 55 7
a Each line contains data from one rat; numbers represent percent of
total radioactivity precipitable by 12% TCA.
b For the animals given nIgG, there was no significant difference
between the saline and MIT rats in the TCA precipitability of radioac-
tivity in plasma, urine, or kidney (P > 0.10, unpaired t-test). Other
groups were not analyzed due to the small number of rats.
studied using a preparation of labeled nIgG which had a lower
percentage of free radioiodine than that used in the second two
rats in each group. In the single saline—infused control rat given
aIgG, there was approximately 26% less TCA precipitability of
radioactivity in the kidney homogenate compared to the MIT-
infused rat given aIgG. However, since in no case was more
than 27% of total filtered aIgG was present in the renal
homogenate pool, this rate of deiodination would cause a
maximum underestimation of filtered marker by 7%. We con-
clude that for the three markers, nIgG, aIgG and Crp, deiodina-
tion of circulating or filtered radioiodinated protein marker does
not occur to a significant degree during the 20 minute time
period used in these sieving studies. This is consistent with
previous studies using radiolabeled native and cationized bo-
vine albumins [16]. The TCA-soluble radioactivity present in
urine, and in smaller amounts, in kidney, must be attributed to
filtration of the small but significant amount of highly—permeant
free radioiodine in the infused labeled marker—preparations.
Sieving experiments: Renal function and marker
accumulation
Results for inulin clearance (C1), rat albumin (RSA) excre-
tion, and rat IgG excretion for all three series (A, B, and C) are
summarized in Table 2. In Series A rats, C1 was significantly
depressed in both proteinuric groups, with a significantly
greater reduction occurring in the HDM group as compared
with the Adna group. In contrast, C1 was not significantly
different among the three groups in Series B. RSA and rat IgG
excretion rates were significantly increased in the experimental
groups (HDM, Adria) in both series. HDM rats excreted more
of both proteins than Adria rats.
Left renal vein samples were obtained successfully in 36 of 40
rats in Series A and B. The mean (± I SEM) renal vein to plasma
inulin ratio was 0.999 0.026, which was not significantly
different from 1.0. The failure of these ureter—ligated left
kidneys to extract inulin confirms the induction of a nonfiltering
state.
To compare renal accumulation of the four labeled markers,
the ratios of TCA-insoluble kidney radioactivity (cpmlg) to









Series A (rats given aIgG and nIgG)
Saline
N = 6 0.51 0.03 <5b <5b
HDM
N = 8 0.22 0.03c 673 81C 130 28C
Adria
N = 7 0.35 0c.d 116 16c,d 40 9
Series B (rats given CRP and nIgG)
Saline
N = 6 0.38 0.07 <5b <5b
HDMN=7 0.27±0.01 470±l45c 84±28c
Adna
N = 6 0.30 0.05 112 2l 8 3
Series C (rats given ESA and nIgG)
Saline
N = 8 0.58 0.06 <S ND
a Values shown are mean I SEM
b Control rats had rates of albumin and IgG excretion below the limit
of detection by IEP (5.0 sg/min for either protein)
c p < 0.05, experimental vs. control
d p < 0.05, Adna vs. HDM
ND, not determined
plasma (P) radioactivity (cpm/ml) were calculated for the fil-
tering right kidney (RK) and the nonfiltering left kidney (LK).
The ratio of total urinary marker (UV, cpmI2O mm) to P was
also calculated. These values are shown in Tables 3 and 4. For
aIgG and nIgG, most of the filtered load of marker in all groups
was present in the urine. With the exception of the Adria rats in
Series B and the Series C rats, the difference RK/P minus LKJP
for the IgGs, although numerically positive, was not signifi-
cantly different from zero (P > 0.05, paired t-test). Thus, in
contrast to the smaller neutral albumin marker used in this and
the previous sieving study [16], the IgG markers of either
charge accumulated in the kidney tissue proportionately more
by direct entry from the vasculature into the interstitium, and
less by glomerular filtration and tubular reabsorption. This
observation is confirmed in Series C, where in a simultaneous
comparison, the reabsorbed fraction of filtered nIgG (0.35) is
significantly less than that of BSA (0.80) (Table 4). For Crp,
RKIP was significantly greater than LK/P for all three groups (P
< 0.05, paired t-test), indicating reabsorption of a significant
portion of the filtered Crp load by the renal tubules of the
filtering right kidney.
Sieving experiments: GSC determinations
The GSC values for the three groups of Series A rats (given
aIgG and nIgG) are shown in Figure 1 and Table 3. In the
control rats, the mean (± 1 SEM) GSC of the anionic aIgG (0.004
0.001) was significantly greater than that of the neutral nIgG
(0.001 0.0003; ratio of aIgG/nIgG = 2.8, significantly greater
than 1.0, P < 0.005). The behavior of these paired high
molecular—weight probes differed markedly from that observed
for the smaller, bovine albumin markers, since filtration of
anionic albumin was much less than that of a neutral molecule
of the same size [16].
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Table 3. Marker accumulation and GSC valuesa
Anionic marker (aIgG or CRP) Neutral marker (nlgG)
Group RKIP LK/P UV/P %R GSC RKIP LKJP UV/P %R GSC
Series A (paired aIgG and nIgG)
0.054 0.081 12 0.004 0.049k' 0.045 0.023 28 0.001Control 0.0561
N = 6 0.013 0.009 0.023 6 0.001 0.010 0.005 0.007 10 0.0003
HDM 0.l28t 0.045 0.439 27 0.060c 0108b 0.040 0.289 18 0.040c
N = 8 0.044 0.008 0.077 9 0.014 0.039 0.006 0.052 8 0.010
Adria 0.05&' 0.055 0.196 14 0.0l7c 0.064k' 0.080 0.210 14 0.019N 7 0.009 0.013 0.064 9 0.006 0.010 0.034 0.078 9 0.008
Series B (CRP and nlgG)
0.123 0.122 71 0.021 0.050" 0.035 0.065 21 0.005Control 0.345N 6 0.053 0.027 0,056 7 0.003 0.005 0.004 0.020 6 0.001
HDM 0.761 0.204 0.491 62 0.087c 0054b 0.034 0.309 10 0,028c
N = 7 0.047 0.016 0.190 8 0.018 0.010 0.003 0.122 5 0.011
Adria 0.230 0.130 0.275 31 0.036' 0.063 0.048 0.243 7 0.027e
N = 6 0.019 0.013 0.028 6 0.008 0.011 0.007 0.041 2 0.010
Values are mean I SEM. Abbreviations are: RKJP, LK/P—ratio of right kidney (RK) or left kidney (LK) radioactivity (cpm/g) to plasma (P)
radioactivity (cpmlml); UV/P—ratio of total urinary marker to P; %R—percent of total filtered marker load reabsorbed in RK, corrected for
interstitial marker as estimated from LK; GSC—glomerular sieving coefficient.
b RKJP not significantly greater than LK/P (P> 0.05, paired 1-test)
P < 0.05, experimental (HDM, Adria) vs. control
d P < 0.05, Adria vs. 11DM
0.103 0.047 80 0.0029 0.065 0.045 35b 0,0025c
0.010 0.007 5 0.0004 0.005 0.005 7 0.0004
Rats rendered proteinuric by HDM or Adria had significantly
increased filtration of both aIgG and nIgG compared to controls
(Fig. 1, Table 3). In the HDM rats, the GSC of aIgG remained
significantly higher than that of nIgG (ratio of aIgG/nIgG =
1.56, greater than 1.0 with P < 0.001), with the absolute value
of the difference between the GSCs of aIgG and nIgG being
even greater than in controls (GSC of aIgG—GSC of nIgG:
controls, 0.003; HDM, 0.020). This outcome would be predicted
if the increase in glomerular permeability in HDM rats was due
to the appearance of a new population of large pores, at least
some of which favor anionic over neutral molecules.
In contrast, GSCs of both IgGs did not differ significantly in
the Adria group (ratio = 1.13). The absolute value of the
difference between the IgGs was unchanged compared to the
controls (controls, 0.003; Adria, 0.002). These results can be
interpreted as showing that in Adria rats, the increase in
filtration of a molecule the size of IgG is due to the appearance
of "pores" which are completely nonselective with respect to
charge.
Because of the unexpected finding of a higher GSC value for
aIgG than for nIgG, the filtration of nIgG was compared to that
of Crp, an unmodified negatively charged protein of similar size
(Series B rats). The results obtained (Fig. 2, Table 3) are in
general agreement with those from Series A. In control rats, the
anionic marker Crp had a significantly higher GSC than nIgG
(mean GSC SEM: Crp, 0.021 0.003; nIgG, 0.005 0.001).
The GSCs for nIgG in the Series B HDM and Adria rats were
both increased to a similar degree, confirming the appearance of
a defect in size—dependent permselectivity in both models.
However, where the GSC for Crp and nIgG were not signifi-
cantly different in the Adria rats, in HDM rats the GSC for Crp
Table 4. Marker accumulation and GSC valuesa; Series C (BSA and
nIgG; control rats only; N = 8)
BSA nIgG
RK/P LK/P %R GSC RKIP LK/P %R GSC
a Values are mean 1 5EM. Abbreviations are as in Table 3
b p < 0.001, nIgG vs. BSA (paired 1-test)










Control HDMN=6 N=8 AdriaN= 7
Fig. 1. Glomerular sieving coefficients (GSC) of algG, p1 4.9 (black
bars) and nIgG, p1 7.4 to 7.6 (open bars) in saline—infused (control) and
proteinuric (HDM, Adria) rats. Bars represent mean I SEM. <
0.05, proteinuric (HDM, Adria) vs. control; tP <0.05, GSC of aIgG vs.
GSC of nIgG; 1P < 0.05, Adria vs. HDM.
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was substantially larger than the GSC for nIgG. This difference
between the Adria and HDM rats provides further evidence that
the new pores in the HDM model favor passage of anionic
species, where those in the Adria model are charge—nonselec-
tive. This is consistent with the observation in the paired
albumin study [16] that Adria rats lost their charge barrier to
molecules the size of albumin. HDM rats in that study retained
substantial charge selectivity for the paired albumin markers,
although neutral albumin was favored over anionic albumin, in
contrast to the findings for the larger molecular probes used in
the current study.
Series C was performed to compare directly in control rats
the filtration of anionic albumin, the principal protein of plasma,
and the larger neutral molecule nIgG (Table 4). The GSC of
BSA (0.0029 0.0004) was slightly but significantly higher than
the simultaneously determined GSC of nIgG (0.0025 0.0004).
This estimate of the GSC of BSA is higher than that previously
reported by this technique (0.0006 0.0002), perhaps in part
due to the use in the current study of somewhat higher amount
of labeled BSA to obtain greater counting accuracy in measur-
ing the small amount of this tracer in the urine and kidney
homogenate.
Discussion
To characterize the filtration of high—molecular—weight pro-
teins in normal rats as well in rats made proteinuric by HDM or
Adria, we used a paired—label tissue accumulation method
previously validated for the study of paired albumins of dif-
fering charge [16]. This method has the advantage of using
biologically relevant proteins as filtration markers. The diffi-
culty presented by tubular reabsorption of filtered protein
markers is overcome by quantitating the reabsorbed fraction in
the right kidney, with correction for interstitial marker as
estimated from radioactivity present in the non-filtering left
kidney. As was the case in the albumin experiments, the IgG
and ceruloplasmin markers employed in the present study were
not significantly degraded to lower—molecular—weight frag-
ments nor deiodinated during the period of time used for the
sieving experiments.
The first important finding in this study is that in the
saline—infused control rats of both Series A (rats given aIgG and
nIgG) and in Series B (rats given Crp and nIgG), the GSCs of
the anionic markers were not reduced compared to that of the
neutral marker (Figs. 1, 2; Table 3). In fact, the GSC values for
aIgG (Series A) and Crp (Series B) were significantly higher
than those of nIgG in the control rats. This is in contrast to our
findings in normal rats studied with paired albumins, in which
the GSC of a neutral albumin was approximately 29 times
higher than that of a native anionic albumin [16], and to the
findings by others of restricted filtration of other smaller anionic
probes, such as succinylated horseradish peroxidase [14] or
dextran sulfates in the size range from 18 to 42 A [2].
The series B experiments, which compared Crp filtration to
that of nIgG, were undertaken for several reasons. First, since
the finding of a higher GSC for aIgG than nIgG was unexpected,
we wished to confirm this observation using an unmodified
protein of similar size and charge to that of aIgG. Second, it is
known that immunoglobulins are secreted across epithelia in
some tissues. Although there is no evidence that IgG can enter
the renal tubules or urinary collecting system in this fashion, we
reasoned that use of a non-immunoglobulin anionic marker
would markedly decrease the possibility that the higher GSC
values for aIgG were due to transepithelial transport.
Recent observations by other groups support the concept that
molecules of the size of IgG may cross the normal glomerular
capillary wall via an alternative "shunt" pathway. Deen et al
[27] have described a heteroporous model of glomerular size
selectivity and tested this model against dextran sieving data
obtained in normal and nephrotic humans. These authors noted
that particularly when data for the sieving of large (>50 A)
dextrans were included in their analysis, mathematical models
based on a single—pore size distribution led to poor agreement
between the model and the experimental data. A much better fit
between the model and the data was achieved using models that
described the capillary wall as having two populations of
"pores". In general, these more accurate heteroporous models
specify one population of smaller pores which have an average
radius of approximately so A, through which 90 to 99% of the
volume flux occurs. Although not specified in the model, it is
presumably this population of pores which is charge selective.
Molecules the size of albumin (35 A) pass through this popula-
tion of pores more or less readily, depending upon their charge.
In this regard, it is interesting that in Series C of our current
study, the GSC of nIgG (0.0025) was only slightly, although
significantly, smaller than the GSC of BSA (0.0029) (Table 4).
This result would be predicted if native, anionic albumin
molecules were almost completely excluded from the popula-
tion of smaller pores because of their negative charge. Then
most of the native albumin crossing the glomerular capillary
wall in normal animals would pass, along with IgG, through the
small population of larger pores. The fact that the GSC of BSA
was significantly higher than that of nIgG when the two are
measured simultaneously could be explained either by a "re-
verse" charge selectivity favoring anionic molecules through
the "shunt" pathway, or by passage of a small amount of BSA
through the small pore pathway despite its negative charge.

















Fig. 2. GSCs of Crp, p1 4.9 (black bars) and nlgG, p1 7.4 to 7.6 (open
bars) in control, HDM, and Adria rats. Bars represent mean I 5EM.
*P < 0.05, proteinuric (HDM, Adria) vs. control; tP < 0.05, GSC of
Crp vs. GSC of nIgG; 1P < 0.05, Adria vs. HDM.
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Deen et al [27] as having an average radius of approximately 70
A, or alternatively described simply as a nonselective "shunt"
pathway available to all macromolecules regardless of size or
charge. lgG (molecular radius 52 A) was essentially excluded
from the population of smaller pores through which most of the
filtration occurs, but passed readily through the larger pores, or
shunt pathway. If the larger pores had the dimensions attributed
to them in these heteroporous models, it is likely that they
would not be charge selective for molecules the size of IgG,
though they might be charge selective for still larger proteins.
The increased filtration of large neutral dextrans found in the
nephrotic patients was accounted for in the model by an
increase in the proportion of glomerular filtrate occurring
through the large pore or "shunt" pathway. In addition, volume
expansion appears to increase the relative importance of the
"shunt" pathway in both normal and nephrotic humans [28].
Since the rats in the current study were volume expanded so
that the animals in the HDM group would tolerate the infusion
of this polycation, it would be anticipated that the preparation
employed would emphasize the role of the large pore pathway,
in comparison to less volume—expanded rats.
The current study supports that concept that large proteins
such as IgG and Crp cross the normal glomerular barrier via a
pathway which is different from that available to smaller
proteins such as albumin. In addition, the increased filtration of
nIgG in the proteinuric rats in this study is compatible with an
increase in the proportion of total pore area represented by the
large pore or "shunt" pathway. However, the heteroporous
model presented by these authors did not take into account
electrostatic effects, and therefore could not predict that the
shunt pathway actually favors anionic molecules, as suggested
by the currently reported results in the normal and 11DM
groups. Only in our Adria groups are the GSCs of neutral and
anionic probes identical, compatible with an increase in a
completely charge—indifferent pathway.
Deen et al [27] found that to a major extent, models describ-
ing the pathway available to large macromolecules either as a
second population of larger pores or as a nonselective "shunt"
pathway performed equally well in predicting their experimen-
tal sieving results. In the current study, we found that Crp,
which is slightly smaller than IgG, had a significantly higher
GSC in normal and HDM proteinuric rats. In addition, in a
previous study [14] we reported that although 11DM rats had
increased amounts of lgG in their urine, higher molecu-
lar—weight proteins present in plasma were not present in urine.
These observations suggest that the pathway traversed by IgG
in normal and proteinuric rats does have size selectivity for
proteins, and is not accurately characterized as an infinitely
large "shunt" in the capillary wall. Models incorporating a
second population of pores, the mean diameter of which is
significantly but not markedly larger than IgG, would be in
closer agreement with our results.
Using an entirely different approach, another group has
provided evidence that IgG molecules of differing charge are
able to penetrate most of the way through the glomerular
capillary wall to an equal degree. Adler et al [29] prepared and
radiolabeled differently—charged IgG antibodies directed
against GBM antigens, administered these labeled antibodies
intravenously into rats, and measured the deposition of these
antibodies in the glomeruli. They found that glomerular depo-
sition of anionic (p1 approximately 4.0 to 6.5) and cationic (p1
6.0 to 9.0) IgG antibody fractions was identical. For comparison
to our study, it is important to note that Adler et al used
Heymann nephritis (anti-FxlA) antibodies of differing charge in
two of their experimental groups. Since the principal antigenic
target(s) of these nephritogenic sera are in a subepithelial
location [30], circulating antibody molecules from these prepa-
rations must pass through the endothelial and basement mem-
brane layers of the capillary wall to reach the site of deposition.
These antibody binding studies, although they do not measure
penetration of IgG across the entire capillary wall, are in
agreement with the present study.
The work by others described above provides precedent for
the observation in the current study that molecules the size of
IgG cross the glomerular capillary wall via a pathway which is
different from that through which smaller proteins travel and
which does not restrict anionic molecules more than neutral
ones. However, we have found that the filtration of large
anionic markers (aIgG, Crp) was actually significantly greater
than that of the paired neutral marker. There have been
previous reports providing evidence for unexpectedly high
filtration of anionic IgG. Galaske, Van Liew and Feld [31]
measured the concentration of radiolabeled proteins in Bow-
man's space after intravenous administration, and found that
native IgG (p1 6.4 to 7.2) had a GSC that was similar to that
found for the IgG markers in our study, and that was actually 12
times higher than that measured for native anionic albumin in
their experiments. However, the extent to which the measured
radioiodine activity was bound to intact protein in the infused
preparation and the capsular fluid samples was apparently not
assessed. Another recent preliminary report [32] also describes
the finding that anionic IgG subclasses appear preferentially in
the urine of normal and nephrotic humans, although differences
in glomerular filtration could not be separated from differences
in tubular reabsorption in this report. It is also intriguing to note
that in the antibody binding studies of Adler et al [29] discussed
above, the deposition of anionic passive Heymann nephritis
IgG was numerically greater than that of cationic IgG prepared
from the same pool of antibody eluate (ratio of cationic to
anionic antibody, 0.37), although this difference was not statis-
tically significant. The report by Melvin, Kim and Michael [33],
demonstrating that normal GBM has regions which bind anionic
molecules and therefore presumably are cationic, may also be
relevant.
The second important finding in this study was that there
were marked increases in filtration of a neutral IgG marker in
rats made proteinuric by HDM or Adria. For the HDM groups,
this finding confirms our previous report [16] that this polyca-
tion alters the size dependence of glomerular permeability.
Since HDM binds to and neutralizes GBM anionic sites, the
most likely interpretation of these results is that at least some
anionic sites must play a role in GBM structure as well as
charge density. In our previous sieving studies using paired
albumins there was no increased filtration of the neutral albu-
min in Adria rats, leading to the conclusion that in this model,
albuminuria is due principally to a loss of charge dependence of
permselectivity. Using the larger probe nIgG, we have now
shown that there is an alteration of size dependence of perm-
selectivity in the Adria model, as previously reported from
neutral dextran—sieving studies performed by others [8]. The
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increase in apparent "pore" size was of lesser magnitude in
Adria rats than in HDM rats (Figs. 1, 2; Table 3), suggesting
that HDM rats had a greater increase in the total area of the
large pore, or "shunt", pathway. In addition, the fact that the
"shunt" pathway continues to favor the anionic markers in the
HDM rats suggests that in this model, proteinuria is due to an
increased number of large pores having "reversed" charge
selectivity, rather than to enlargement of large uncharged
pores. Even though the total area available for filtration of large
proteins such as IgG would be markedly increased, charge
selectivity would be retained for the barrier as a whole because
each individual pore would retain its charge characteristics. In
contrast, the Adria rats appear to lose charge selectivity of both
populations of pores, so that the filtration of molecules the size
of albumin or IgG becomes independent of charge. The differ-
ence between the two models of proteinuria must be qualitative
as well as quantitative.
In summary, we have used a previously validated,
paired—label sieving method to quantitate the filtration of large
anionic and neutral molecules in normal and proteinuric rats. In
normal rats, the filtration of the large anionic markers was not
reduced compared to that of a paired neutral marker of the same
size, indicating that markers of this size cross the glomerular
capillary wall by a pathway different from that available to a
smaller molecule such as cationized, neutral albumin. In con-
trast to the smaller, more abundant "pores" through which
most of the filtrate passes, this "shunt" pathway appears to
favor anionic molecules. In proteinuric rats, increased filtration
of these large molecules of either charge could be accounted for
by an increase in the total area of this "shunt" pathway. In
Adria rats, the new pores appear to be non-selective with
respect to charge. In HDM rats, the structural alteration
induced by the polycation may be characterized as an increase
in the "shunt" pathway which continues to display the pattern
of charge selectivity for large molecules shown by normal rats,
with increased filtration of large anionic molecules. The findings
are compatible with recently—described heteroporous models of
glomerular size selectivity, and support the idea that the
glomerular capillary wall must have different pathways avail-
able to solutes in different size ranges.
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